Cite

HARVARD Citation

    Wright, K. et al. (n.d.). CTNI-19. PHASE I TRIAL OF DAY101 IN PEDIATRIC PATIENTS WITH RADIOGRAPHICALLY RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA (LGG). Neuro-oncology. p. ii46. [Online]. 
  
Back to record